Effect of risk-reducing salpingo-oophorectomy on the quality of life in Korean BRCA mutation carriers

• Published in: Asian journal of surgery 2021-08, Vol.44 (8), p.1056-1062
• Main Authors: Chae, Sumin, Kim, Eun-Kyu, Jang, Ye Rang, Lee, Angela Soeun, Kim, Seul Ki, Suh, Dong Hoon, Kim, Kidong, No, Jae Hong, Kim, Yong-Beom, Kim, Sung-Won, Kang, Eunyoung
• Format: Article
• Language: English
• Subjects: BRCA mutation Carriers; Quality of life; Risk-reducing salpingo-oophorectomy
• ISSN: 1015-9584
• DOI: 10.1016/j.asjsur.2021.01.007

This study aimed to compare the quality of life (QOL), psychosocial status, sexual function, and menopausal symptoms between the risk-reducing salpingo-oophorectomy (RRSO) and non-RRSO groups comprising BRCA mutation carriers and to evaluate the effect of timing of RRSO on those aspects. This cross-sectional study recruited BRCA mutation carriers aged ≥35 years between September 2015 and September 2016. Demographic data of carriers were collected. Outcomes were measured using the questionnaires addressing QOL, anxiety, depression, optimism, sexual function, and menopausal symptoms. Of 52 participants, 30 (57.7%) underwent RRSO, whereas 22 (42.3%) did not. In the RRSO group, 16 (53.3%) and 14 (46.7%) women underwent RRSO before and after menopause, respectively. The mean age in the RRSO group was higher than that in the non-RRSO group (49.8 vs. 42.1 years, respectively, p = 0.002). The scores for QOL, anxiety, depression, optimism, sexual function, and menopausal symptoms were similar between both groups. In the multivariate analysis, RRSO uptake was associated with worse physical QOL (coefficient, −5.350; 95% confidence interval, −10.593 to −0.108). With respect to the timing of RRSO, only the mental QOL was significantly lower in the postmenopausal RRSO group than in the premenopausal RRSO group (39.2 vs. 43.7, respectively, p = 0.043). We could not find any difference in mental QOL, psychosocial status, sexual function, and menopausal symptoms between the RRSO and non-RRSO groups. RRSO uptake only affected worse physical QOL. These results will help physicians counsel BRCA mutation carriers about the effect of RRSO on QOL.